The daily medication, called hydromethylthionine mesylate (HMTM), was developed by British firm TauRX in Aberdeen ...

A ‘GAME-changing’ drug which could slow down Alzheimer’s disease is being considered for potential use on the NHS. The daily medication, called hydromethylthionine mesylate ...

Officials are assessing whether hydromethylthionine mesylate (HMTM) shows sufficient promise to be given the green light for ...

INR:1778. gemballa free play How do Ionis pipeline drugs fight dementia and ALS? "Allogeneic" CAR-T therapy shows early efficacy in lymphoma treatment Johnson ...

A new study offers an explanation as to how deep sleep — also known as slow wave sleep — helps support the formation of ...

Hormone Modulating Therapy (HMT), widely used to treat hormone receptor-positive breast cancer, could offer more than just ...

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

New research sheds further evidence that when tailored to individual needs, music therapy can significantly help patients ...

This University of Waterloo study shows how antipsychotic medications significantly worsened behavior in nursing home ...

In this season of short days and long winter nights, it's easy to feel out of sorts. Those who suffer from seasonal affective disorder, a form of depression that's closely linked to the circadian ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...